Elizabeth Warren wants Gilead CEO Daniel O’Day in the hot seat to talk drug pricing and competitiveness

Elizabeth Warren

Given Gilead’s experience in developing storied new drugs for hepatitis C and Covid-19, and marketing them with hefty price tags, Massachusetts Sen. Elizabeth Warren (D) sent a letter on Friday to CEO Daniel O’Day, calling on him to testify before a subcommittee of...

Click to view original post